NEW YORK (GenomeWeb News) – Celera said today that it has begun a multi-year research collaboration with the Pennsylvania-based health services company Geisinger Health System to develop an assay for diagnosing a liver condition called non-alcoholic steatohepatitis or NASH.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.